Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.

BMC cancer - 27 Jul 2020

Lee Sun-Young, Chae Dong-Kyu, Lee Sung-Hun, Lim Yohan, An Jahyun, Chae Chang Hoon, Kim Byung Chul, Bhak Jong, Bolser Dan, Cho Dong-Hyu

Abstract excerpt

BACKGROUND: Early diagnosis and continuous monitoring are necessary for an efficient management of cervical cancers (CC). Liquid biopsy, such as detecting circulating tumor DNA (ctDNA) from blood, is a simple, non-invasive method for testing and monitoring cancer markers. However, tumor-specific alterations in ctDNA have not been extensively investigated or compared to other circulating biomarkers in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenosine Triphosphatases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Squamous Cell

Share to Circulating Tumor DNA

Share to Class I Phosphatidylinositol 3-Kinases

Share to Proto-Oncogene Proteins p21(ras)

Share to Ubiquitin-Protein Ligases

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 32718341
DOI: 10.1186/s12885-020-07161-0
PMCID: PMC7385901

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.PMID 32718341Read ↗

Characterization of the Genomic Landscape in Cervical Cancer by Next Generation SequencingSemantic proximity Read ↗

Comprehensive circulating tumor DNA mutation profiling via CAPP-Seq liquid biopsy for cervical cancer.Semantic proximity Read ↗

Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types.Semantic proximity Read ↗

Genomic Profiling of Chinese Cervical Cancer Patients Reveals Prevalence of DNA Damage Repair Gene Alterations and Related Hypoxia FeatureSemantic proximity Read ↗

Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer.Semantic proximity Read ↗

Genomic Profiling of NGS-based ctDNA from Chinese Non-Small Cell Lung Cancer PatientsSemantic proximity Read ↗

Comprehensive landscape and interference of clonal haematopoiesis mutations for liquid biopsy: A Chinese pan-cancer cohort.Semantic proximity Read ↗

Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep SequencingSemantic proximity Read ↗

Baseline mutation profiling of 1134 samples of circulating cell-free DNA and blood cells from healthy individualsSemantic proximity Read ↗

Genetic profiles of cervical tumors by high-throughput sequencing for personalized medical care.Semantic proximity Read ↗

Mutation Profile Assessed by Next-Generation Sequencing (NGS) of Circulating Tumor DNA (ctDNA) in Chinese Lung Adenocarcinoma Patients: Analysis of Real-World Data.Semantic proximity Read ↗

Next-Generation Sequencing of Plasma Cell-Free DNA for Treatment Monitoring in Advanced Head and Neck Cancer Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.